Spyre Therapeutics logo
Spyre Therapeutics
SYRE | NASDAQ
Chart Builder DCF Calculator
$99.37
-$4.63 (-4.45%)
At close: Nov 16, 2026, 4:00 PM ET
$99.37
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET

Spyre Therapeutics Cash Flow Statement

Cash flow statement explained
Fiscal Quarter
Period Ending
Q3 2026
Sep 30, 2026
Q2 2026
Jun 30, 2026
Q1 2026
Mar 31, 2026
Q4 2025
Dec 31, 2025
Q3 2025
Sep 30, 2025
Q2 2025
Jun 30, 2025
Q1 2025
Mar 31, 2025
Q4 2024
Dec 31, 2024
Q3 2024
Sep 30, 2024
Q2 2024
Jun 30, 2024
Q1 2024
Mar 31, 2024
Q4 2023
Dec 31, 2023
Q3 2023
Sep 30, 2023
Q2 2023
Jun 30, 2023
Q1 2023
Mar 31, 2023
Q4 2022
Dec 31, 2022
Q3 2022
Sep 30, 2022
Q2 2022
Jun 30, 2022
Q1 2022
Mar 31, 2022
Q4 2021
Dec 31, 2021
Q3 2021
Sep 30, 2021
Q2 2021
Jun 30, 2021
Q1 2021
Mar 31, 2021
-96.12M -36.2M -69.01M -62.53M -11.18M -36.72M -44.77M -56.3M -69.03M -38.84M -43.86M -63.18M -40.11M -217.08M -18.42M -18.82M -18.23M -22.32M -24.44M -20.45M -20.31M -6.83M -18.22M
– – – – – – – – – – – -220K – 416K 548K 385K 502K 475K 403K 411K 412K 398K 355K
14.17M 13.51M 12.81M 9.81M 9.57M 9.38M 8.86M 9.22M 13.1M 8.68M 13.84M 17.27M 4.79M 1.91M 1.71M 1.43M 1.57M 2.02M 2.1M 2.09M 2.11M 2.08M 1.76M
4.76M -8.96M 3.42M -3.12M 2.2M -9.06M -5.54M 31.28M 8.42M -35.79M 7.77M -1.08M -8.39M 6.63M -2.79M 2.05M -890K -586K -3.87M -2.97M 830K -15.43M 18.34M
-4.08M -38.26M -1.42M 10.41M -41.44M -10.18M -4.51M -917K 16.16M -2.94M -1.99M 18.66M 8.68M 192.14M -105K 28K -33K 225K 78K 186K 293K 44K 115K
– – – – – – – – – – – -1.71M – – – – – – – – – – –
8.54M -8.93M 244K -2.27M 5.94M -9.04M -568K 10.8M 10.35M -29.16M 3.47M -1.86M -7.95M 5.97M -1.36M -1.16M 1.13M -1.07M -4.41M -1.51M 495K 6.39M -3.54M
-77.5M -69.88M -57.37M -44.58M -37.12M -46.56M -40.99M -37.2M -29.42M -62.25M -28.54M -31.04M -34.6M -16.64M -17.63M -18.14M -15.07M -20.67M -26.26M -19.27M -17M 2.08M -19.53M
– – – – – – – – – – – – – – – – -1K – -37K – -93K -30K -450K
– – – – – – – – – – – -15.48M – 475K – – – – – – – – –
-138.28M -447.34M -81.17M -341.71M -74.19M -34.87M -71.44M -233.09M -35.05M -178.39M -152.71M -54.17M -112.63M – – -4.5M -7.25M -24.25M -3.5M -13.25M -26.25M -69.33M -24.25M
134.48M 109.44M 107.75M 94.3M 99.19M 106.87M 71.38M 62.55M 77.79M 57.88M 47.75M 18.9M – 3.25M 17.75M 18.5M 23.75M 25M 29.3M 22.91M 32.12M 22M 34M
– 40M 30M – – 7M – – – – – 15.48M 15M 3.04M – – – – – – – – –
-3.8M -297.9M 56.58M -247.41M 25M 79M -61K -170.54M 42.74M -120.52M -104.96M -35.27M -97.63M 6.76M 17.75M 14M 16.5M 750K 25.76M 9.66M 5.78M -47.36M 9.3M
– – – – – – – – – – – – – -8K -8K -8K -63K -175K -172K -169K -108K -228K -5K
– – – – – – -117K – – – – – – – – – – – – – – – –
– – – – – – – – – – – – – – – – – – – – – – –
-33.1M -23.38M -171K -69K -5.13M -117K 242K 979K 1.24M 169.7M -166.25M -5.79M 105K – 18K – 38K 42.98M 184K 249K 1.25M 36K 367K
2.02M 432.6M 12.26M 312.81M -4.64M 731K 125K 225.6M 12.78M 360K 172.17M 163.61M -12.53M 209.99M 10K -8K -130K 42.8M 12K 80K 1.14M -192K 362K
-79.28M 64.82M 11.46M 20.82M -16.76M 33.17M -40.93M 17.84M 26.12M -182.41M 38.66M 97.32M -144.78M 200.12M 137K -4.1M 1.24M 22.81M -515K -9.52M -10.11M -45.47M -9.86M
-77.5M -69.88M -57.37M -44.58M -37.12M -46.56M -40.99M -37.2M -29.42M -62.25M -28.54M -31.04M -34.6M -16.64M -17.63M -18.14M -15.07M -20.67M -26.3M -19.27M -17.09M 2.05M -19.98M
-91.66M -83.39M -70.18M -54.39M -46.68M -55.94M -49.85M -46.42M -42.52M -70.93M -42.38M -48.31M -39.38M -18.55M -19.34M -19.57M -16.64M -22.69M -28.4M -21.36M -19.2M -28K -21.74M
– – – – – – – – – – – – – – – – -1K – – – – – -450K
– – – – – – – – – – – – – – – – – – -37K – -93K -30K –
-77.5M -69.88M -57.37M -44.58M -37.12M -46.56M -40.99M -37.2M -29.42M -62.25M -28.54M -31.04M -34.6M -16.64M -17.63M -18.14M -15.07M -20.67M -26.26M -19.27M -17M 2.08M -19.98M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.